Variable | Patients, n (%) |
---|---|
Newly developed symptoms | 9 (56.3) |
CN VII–VIIIa | 1 (6.2) |
CN IX–XIIb | 5 (31.3) |
CN VII–VIII and CN IX–XII | 3 (18.8) |
Neither CN VII–VIII nor CN IX–XIIc | 0 (0.0) |
Aggravation of pre-existing symptoms | 7 (43.7) |
CN VII–VIIIa | 0 (0.0) |
CN IX–XIIb | 5 (31.2) |
CN VII–VIII and CN IX–XII | 2 (12.5) |
Neither CN VII–VIII nor CN IX–XIIc | 0 (0.0) |